BioSpace News Archive

ArQule, Inc. announced that Marc Schegerin, Chief Financial Officer and Head of Strategy, will present at the BMO Prescriptions for Success Healthcare Conference on June 25, 2019 at 8:00 a.m. ET at the The Mandarin Oriental New York, New York.

Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announces the development of an innovative alternative approach to breath-based testing through the utilization of Exogenous Volatile Organic Compound (EVOC®) Probes

Technology innovators in super-resolution microscopy, Amsterdam-based Confocal.nl, have been selected as one of ten winners of the Academic Startup Competition in the Netherlands, an initiative of the Association of Universities (VSNU), the Netherlands Academy of Technology and Innovation (AcTI) and StartupDelta.

CARB-X is awarding Oxford Drug Design Ltd. of Oxford, UK, up to $2.55 million in funding with the possibility of $4.24 million more if certain project milestones are met, to develop a new class of antibiotics for the treatment of Gram-negative bacterial infections using an approach designed to reduce the likelihood that resistance will emerge.

In National Harbor, MD at the Society for Vascular Surgery’s 2019 Vascular Annual Meeting, vascular surgeon Alexandros Mallios, M.D. of Institut Mutualiste Montsouris of Paris, France presented his two year experience performing non-surgical creation of AV fistulae utilizing the FDA cleared Ellipsys® Vascular Access System from Avenu Medical, Inc.

Physicians’ Education Resource® (PER®), a worldwide leading resource for continuing medical education, announces the full agenda for the 20th Annual International Lung Cancer Congress®.

LCGC, a leading multimedia platform of peer-reviewed technical information on the field of chromatography and the separation sciences, will host a live webcast, “Better Insights into Charge Variants of Therapeutic IgGs” on Friday, June 21, at 11 a.m. EDT.

Rising Pharmaceuticals, a Rising Pharma Holdings Inc. company, today announced the U.S. launch & commercial shipment of a generic version of Canasa®, (mesalamine) Suppository, in 1,000 mg strength.

Foster Corporation, a leader in polymer material solutions for the medical and pharmaceutical markets, has seen its business flourish in the last few years

Signant Health (formerly CRF Health and Bracket) will provide expert insights at the forthcoming DIA Global Annual Meeting in San Diego, CA., from 23-27 June 2019.